SIBO, Immune Activation, and FGIDs in Children (SIBO)
Relationship Between Small Intestinal Bacterial Overgrowth (SIBO) and Immune System Activation in Childhood Abdominal Pain-Related Functional Gastrointestinal Disorders (FGIDs)
Sponsor: The University of Texas Health Science Center, Houston
Listed as NCT02872961, this observational or N/A phase trial focuses on Functional Abdominal Pain and Functional Dyspepsia and remains completed. Sponsored by The University of Texas Health Science Center, Houston, it has been updated 14 times since 2013, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Apr 2021 — Dec 2021 [monthly]
Completed
-
Feb 2021 — Apr 2021 [monthly]
Completed
Status: Unknown Status → Completed
▶ Show 9 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2020 — Nov 2020 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Jun 2020 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Texas Health Science Center, Houston
For direct contact, visit the study record on ClinicalTrials.gov .